Costs by Site of Service for Commercially-Insured Patients with Metastatic Pancreatic Cancer Receiving Guideline-Recommended Chemotherapy: Comparing Community Oncology and Hospital Outpatient Settings

PURPOSE: Compare total cost of care (TCOC) for commercially-insured patients with metastatic pancreatic cancer receiving FDA-approved/NCCN Category 1 preferred regimens in community oncology or hospital outpatient settings. PATIENTS AND METHODS: We used the 2016–2019 MarketScan(®) and Milliman Conso...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomicki, Samantha, Dieguez, Gabriela, DeStephano, David, Chang, Melody, Cockrum, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563737/
https://www.ncbi.nlm.nih.gov/pubmed/36250036
http://dx.doi.org/10.2147/CEOR.S373316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563737/
https://www.ncbi.nlm.nih.gov/pubmed/36250036
http://dx.doi.org/10.2147/CEOR.S373316

Ejemplares similares